You are here:

  1. Home
  2. NICE guidance
  3. Topic prioritisation

Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [TSID12287]

  • Topic prioritisation
  • Project information
  • Project documents

34081-Pozelimab-Cemdisiran-for-Myasthenia-Gravis-V1.0-SEP2025-NON-CONF.pdf34081-Pozelimab-Cemdisiran-for-Myasthenia-Gravis-V1.0-SEP2025-NON-CONF.pdf

Back to top